| 000 | 01526 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512200600.0 | ||
| 264 | 0 | _c19851213 | |
| 008 | 198512s 0 0 eng d | ||
| 022 | _a1046-9516 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBigelow, G E | |
| 245 | 0 | 0 |
_aProgress report from the Division of Behavioral Biology, the Johns Hopkins University School of Medicine. _h[electronic resource] |
| 260 |
_bNIDA research monograph _c1984 |
||
| 300 |
_a66-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aButorphanol _xadministration & dosage |
| 650 | 0 | 4 |
_aCodeine _xadministration & dosage |
| 650 | 0 | 4 | _aConditioning, Operant |
| 650 | 0 | 4 |
_aDiazepam _xpharmacology |
| 650 | 0 | 4 |
_aDiscrimination Learning _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMorphine _xadministration & dosage |
| 650 | 0 | 4 |
_aNalbuphine _xadministration & dosage |
| 650 | 0 | 4 |
_aNarcotics _xadministration & dosage |
| 650 | 0 | 4 |
_aOxazepam _xpharmacology |
| 650 | 0 | 4 |
_aPentazocine _xadministration & dosage |
| 650 | 0 | 4 |
_aPupil _xdrug effects |
| 650 | 0 | 4 | _aSelf Administration |
| 700 | 1 | _aBrady, J V | |
| 700 | 1 | _aGriffiths, R R | |
| 700 | 1 | _aStitzer, M L | |
| 700 | 1 | _aAtor, N A | |
| 700 | 1 | _aHiggins, S T | |
| 700 | 1 | _aLiebson, I A | |
| 700 | 1 | _aLucas, S E | |
| 773 | 0 |
_tNIDA research monograph _gvol. 55 _gp. 66-75 |
|
| 999 |
_c6152769 _d6152769 |
||